Matarin Capital Management’s CVS Health CVS Stock Holding History

Matarin Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-25,130	Closed	-$1.49M	–	202
2020 Q1	$1.49M	Sell	25,130 -9,431	-27%	-$630K	0.23%	148
2019 Q4	$2.57M	Buy	+34,561	New	+$2.43M	0.25%	147
2016 Q4	–	Sell	-15,258	Closed	-$1.36M	–	236
2016 Q3	$1.36M	Sell	15,258 -34,268	-69%	-$3.23M	0.15%	169
2016 Q2	$4.74M	Buy	49,526 +2,275	+5%	+$227K	0.64%	64
2016 Q1	$4.9M	Buy	47,251 +453	+1%	+$44K	0.68%	54
2015 Q4	$4.58M	Buy	46,798 +30,949	+195%	+$3.03M	0.68%	57
2015 Q3	$1.53M	Sell	15,849 -6,166	-28%	-$648K	0.31%	106
2015 Q2	$2.31M	Hold	22,015	–	–	0.66%	62
2015 Q1	$2.27M	Buy	22,015 +7,212	+49%	+$730K	0.69%	57
2014 Q4	$1.43M	Hold	14,803	–	–	0.63%	79
2014 Q3	$1.18M	Hold	14,803	–	–	0.54%	88
2014 Q2	$1.12M	Buy	14,803 +7,080	+92%	+$535K	0.5%	93
2014 Q1	$578K	Buy	+7,723	New	+$546K	0.34%	110

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Matarin Capital Management's CVS Position: Q2 2020 in Review

Matarin Capital Management sold out of CVS Health (CVS) in Q2 2020, closing a stake of 25,130 shares — an estimated $1.49M sold.

Matarin Capital Management first reported a position in CVS in Q1 2014 and held it in 13 quarters. The position peaked at $4.9M in Q1 2016. 1,863 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

Matarin Capital Management reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
Matarin Capital Management sold 25,130 CVS Health shares in Q2 2020, an estimated $1.49M.
Matarin Capital Management first reported a position in CVS Health in Q1 2014 and held it in 13 quarters.
Matarin Capital Management's CVS Health position peaked at $4.9M in Q1 2016.
1,863 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Matarin Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.